LMNA related cardiac diseases information and network
News, blogs, information and events on LMNA cardiac diseases and gene mutations.
The 2022 inaugural Global Heart Hub Cardiomyopathy Awareness Week Campaign aims to improve awareness, diagnosis and management of cardiomyopathy. The 2022 campaign theme is ‘Get to the heart of it’. The awareness campaign is led by the Cardiomyopathy Patient Council of the Global Heart Hub. The Cardiomyopathy Patient Council was formed in November 2021 and […]
During this webinar; critical information regarding genetic components of dilated cardiomyopathy, and Pfizer’s exciting Phase 3 Clinical Trial for which they are recruiting patients with the LMNA variant. Topics of the webinar include: – Genetics and progressive stages of DCM – Diagnosis, Evaluation of Family Disease Risk, and Treatment – Explanation of Pfizer’s Phase 3 […]
Phlox Therapeutics, a biotech spin-off of the Amsterdam University Medical Center founded by prof. dr. Yigal Pinto and prof. dr. Eva van Rooij, with Margien Boels, PhD as its initiating director of operations have announced the closure of its seed investment round. This pre-seed investment will be used to advancePhlox’s lead program focused on rare […]
WEBINAR INVITATION Therapies & Hope for LMNA-related DCM Patients During this webinar, organized by DCM foundation, critical information regarding genetic components of dilated cardiomyopathy, and Pfizer’s exciting Phase 3 Clinical Trial for which they are recruiting patients with the LMNA variant will be shared. Topics of the webinar will include:– Genetics and progressive stages of […]
RECORDED LMNA RESEARCH MEETING Discovering a cure for LMNA: Current strategies, crazy ideas and future collaborations Dear Sir, Madam, Thank you for joining the Research meeting focused on Lamin A/C Cardiomyopathy last Wednesday, April 13, 2022. We enjoyed it a lot and hope you did as well! 1. RecordingWe are happy to share the full recording of the Zoom […]
LMNAcardiac.org is a new network for experts and patients focussed on LMNA cardiac diseases, with the aim of accelerating research and development to find effective treatments. The disease is caused by mutations in the LMNA gene, and is characterized by a high rate of major cardiac events caused by impaired contraction of the heart. Catalyze completed a Market […]
In collaboration with “Spierziekten Nederland”, we organized an online meeting about LMNA gene mutations. You can watch the recording on our YouTube channel. In samenwerking met Spierziekten Nederland hebben we een online bijeenkomst georganiseerd over LMNA-gen mutaties. Je kunt de video-opname terugzien.
